Short description
Cognoptix develops non-invasive eye tests for the early diagnosis of alzheimer disease.
Description
Cognoptix is creating and developing an innovative, non-invasive eye test to assist in the early diagnosis of Alzheimer's Disease. Cognoptix's goal is to provide clinicians with a quick, predictive, reliable, inexpensive, and widely available test, enabling early diagnosis and treatment.
The company was founded in 2001 and headquartered in Marlborough, Massachusetts.
Total funding
$$2020202
Sign in for full access
Location
Marlborough, Massachusetts, United States, North America
Founded on
January 1, 2001
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$1230 - 4560
Sign in for full access
Investors
Noaccess, Noaccess, Blurry Noaccess, Cannot Access, Nopepepe, Cannot Access, Noway Youcantaccess, Noaccess, Nopepepe, Noaccess, Noaccess, Uh Ohhhh, Absolutely Noaccess
Sign in for full access
Founders
Lee Goldstein, Leo Chylack